Regional Myocardial Blood Flow and Coronary Reserve in Hypertensive Patients
Authors:
- 1 January 1992
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 44 (Supplement) , 48-55
Abstract
Patients with essential arterial hypertension demonstrate abnormal vasodilator capacity either during increased cardiac metabolic demand or during pharmacological vasodilation. Structural and functional damage to the coronary microcirculation has been proposed as one of the major causes of impaired coronary reserve in this disease. To assess the role of microvascular impairment in regional myocardial blood flow (MBF), 27 patients with essential hypertension were evaluated by dynamic positron emission tomography (PET) at rest, during atrial pacing and after dipyridamole infusion and compared with 13 healthy subjects. All patients had normal coronary arteries, 17 had moderate to severe hypertension and 10 had mild hypertension. Baseline mean MBF of 0.97 ± 0.25 ml/min/g was significantly increased to 1.60 ± 0.38 during atrial pacing and 2.35 ± 0.95 after dipyridamole infusion (p < 0.01); however, mean flow during atrial pacing and after dipyridamole infusion was significantly lower than in healthy subjects (2.15 ± 0.73 and 3.71 ± 0.86 ml/min/g, p < 0.05 and p < 0.01, respectively). The MBF response to atrial pacing and dipyridamole infusion was similarly depressed in patients with mild and severe hypertension. The study was repeated after 6 months of antihypertensive treatment with the calcium antagonist verapamil or the angiotensin converting enzyme (ACE) inhibitor enalapril in a subgroup of 20 patients as part of a randomised, single-blind clinical trial. This study is still in progress; the initial 16 patients treated with verapamil or enalapril showed an obvious improvement in MBF values during atrial pacing and after dipyridamole infusion after 6 months of therapy (mean MBF: 2.10 ± 0.64 and 2.99 ± 1.63 ml/min/g. respectively, p < 0.05 vs pretreatment values). In conclusion, obvious impairment of MBF during atrial pacing and after dipyridamole infusion was observed in hypertensive patients with normal coronary arteries and this appeared unrelated to the severity of hypertension. Therapy with verapamil or enalapril improved coronary reserve and MBF response to an increase in myocardial oxygen demand.Keywords
This publication has 23 references indexed in Scilit:
- Response of the coronary vasculature to myocardial hypertrophyJACC, 1990
- Comparison of verapamil and propranolol therapy for angina pectoris at rest: A randomized, multiple-crossover, controlled trial in the coronary care unitThe American Journal of Cardiology, 1986
- Altered calcium handling in experimental pressure-overload hypertrophy in the ferret.Circulation Research, 1985
- Failure of antihypertensive therapy with diuretic, beta-blocking and calcium channel-blocking drugs to consistently reverse left ventricular diastolic filling abnormalitiesThe American Journal of Cardiology, 1984
- Acute effects of captopril on the coronary circulation of patients with hypertension and anginaThe American Journal of Medicine, 1984
- Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries.Circulation, 1984
- Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failureThe American Journal of Cardiology, 1982
- Regional myocardial blood flow during exercise in dogs with chronic left ventricular hypertrophy.Circulation Research, 1981
- Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failureAmerican Journal of Physiology-Legacy Content, 1973
- Impaired left ventricular relaxation during pacing-induced ischemiaThe American Journal of Cardiology, 1973